Drug theft in the supply chain to be studied by HDMA's research center
Study is sponsored by IT vendor Axway
Booz & Company (New York) is the vendor chosen by HDMA’s Center for Healthcare Supply Chain Research to assess the vulnerability of industry distribution and shipping process to theft and IT incursions. The study, sponsored by IT vendor Axway (Scottsdale, AZ) will look at how vulnerable current industry practices are to data loss, or theft and diversion of shipped product. Theft and diversion are close cousins of counterfeiting, which has been a worry of the industry for years. And while counterfeiting was the spur to the development of state-level pedigree rules across the country over the past six or so years, as much revenue or more can be at risk in theft, lost profits or liability from diverted products.
"In recent years, the industry has made progress in instituting physical and IT safeguards to prevent security breaches," says Paul Fowler, Axway’s VP for healthcare innovation. "However, the industry is still working to understand and target strategies used to exploit vulnerabilities. We’ve worked closely with both manufacturers and distributors to develop and implement solutions to secure the pharmaceutical supply chain, and our work with the Center is yet another example of that effort."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
